Both immune and mesangial cells interacted with cancer cells of the EMT program via the FGFR2 receptor of the FGF family (Figure 7C), with evidence indicating the pivotal role of FGFR2 in mediation of EMT and cancer cell angiogenesis [31]. Here, FGFR2 is linked to cancer.